Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05890_nanopub.RAxywL_YHWC9FegMkYK97khQrFlsEj58MKOglNVNUURCk#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05890 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05890 label "VEGF-AS [drugbank:DB05890]" assertion.
- drugbank:DB05890 seeAlso DB05890 assertion.
- drugbank:DB05890 description "VEGF-AS (Veglin) is an anti-angiogenesis non-chemotherapy drug (angiogenesis inhibitor) that was developed by VasGene Therapeutics, Inc. for the treatment of a variety of malignancies including mesothelioma. Veglin is one of several newly developed non-chemotherapy drugs being tested for possible utilization in the ongoing struggle to combat malignant mesothelioma." assertion.
- drugbank:DB05890 identifier "drugbank:DB05890" assertion.
- drugbank:DB05890 title "VEGF-AS" assertion.
- drugbank:DB05890 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05890 drugbank_vocabulary:drugbank-id "DB05890" assertion.
- drugbank:DB05890 bio2rdf_vocabulary:x-identifiers.org DB05890 assertion.
- drugbank:DB05890 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05890" assertion.
- drugbank:DB05890 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05890 bio2rdf_vocabulary:identifier "DB05890" assertion.